BeStock  
Stocks › Biotechnology › PGEN

Precigen PGEN

US equityMarket cap rank #2555Biotechnology
$7.74 −$0.80 (-9.37%)
Pre-market · Oct 6, 4:10 am ET · After hours $7.80 +0.76%
Open$8.51
Prev close$8.54
Day range$7.55 – $8.60
Volume10.25M
Market cap$2.77B
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-7.2x
CheapRich

Near the bottom of its 5-year range · 8th percentile, 5-year average -1.2x

P/E over five years

-13x-3x8x18xOct '21Apr '24Oct '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$7.76
Price vs. fair value-0.3%Close to the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyHigh
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PE -7.23 16.72 -1.19 8% (cheaper than usual) –

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Morningstar view

Star rating★★★
Fair value estimate$7.76
Economic moatNone
UncertaintyHigh

Discussion

No comments yet — be the first to weigh in on PGEN.

Leave a comment

Scroll to Top